Diane E. Meier, MD, FACP, Director, Center to Advance Palliative Care, Icahn School of Medicine at Mount Sinai talks about how to reduce the attrition rates among palliative care specialists. According…
Adi Jaffe, PhD, Co-Founder and Executive Director, Alternatives Behavioral Health, talks about considerations treatment centers should take before using the Soberlink device for their patients. According to Jaffe, the Soberlink should…
John Weinberg, MD, COO, Veloxis Pharmaceuticals describes the challenges of organ transplantation. While advancements in the field have minimized the short-term risks of transplantation, the average kidney transplant only lasts…
Yaron Daniely, PhD, MBA, CEO of Alcobra Pharma, talks about the problems with current medications for ADHD. First class medications against ADHD include scheduled stimulants such as Ritalin, Adderall,…
Neil Jacobstein, Co-Chair of A.I. and Robotics, Singularity University, discusses the need for medical artificial intelligence to reduce medical errors. As a new generation of doctors begins practice, an…
Neil K. Warma, President & CEO, Opexa Therapeutics, delves into Opexa’s Phase 2B ABILI-T Clinical Trial for secondary progressive multiple sclerosis (MS) that expects to yield top-line results in 2016. Previous studies showed that with…
Martin Lee, director, Project CBD, talks about the JAMA article that highlights the 25 percent decrease in overdose deaths from opiates in states where medical marijuana is legal. According…
Ermias D. Belay, MD, Associate Director for Epidemiologic Science, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention…
Valerie A. Gustave, MD, MPH, attending physician, Gotham Medical Associates, describes the symptoms of acute pancreatitis, which include: nausea, vomiting, abdominal pain, and general unease. The prognosis for…